Recommendations for the diagnosis and treatment of connective tissue disease associated pulmonary arterial hypertension in China
10.3760/cma.j.cn112138-20220309-00164
- VernacularTitle:结缔组织病相关肺动脉高压诊疗规范
- Author:
Xiao ZHANG
1
;
Jiuliang ZHAO
;
Feng DING
;
Jing YANG
;
Jing WANG
;
Xiaofeng ZENG
;
Yan ZHAO
Author Information
1. 广东省医学科学院 广东省人民医院 风湿免疫科，广州 510120
- Keywords:
Hypertension,pulmonary;
Connective tissue diseases;
Diagnosis;
Treatment;
Prognosis
- From:
Chinese Journal of Internal Medicine
2022;61(11):1206-1216
- CountryChina
- Language:Chinese
-
Abstract:
Pulmonary arterial hypertension (PAH) is a clinicopathological syndrome caused by the increase of pulmonary artery, and it is the most serious complication of connective tissue disease (CTD). In recent years, a lot of progress has been made in the diagnosis, treatment and evaluation of PAH. Chinese Rheumatology Association formulated this recommendation on the basis of current experience and guidelines, in order to promote early screening, early diagnosis and early intervention of CTD-PAH, as well as patient follow-up and management, to improve the prognosis of CTD-PAH patients.
